Skip to main content
. 2019 Feb 15;11(2):81. doi: 10.3390/pharmaceutics11020081

Figure 6.

Figure 6

Structure of PLL-g-PEG/DPA/TPS/PheA (probe 1) and schematic illustration of the pH-activable probe 1.